Their presence in IBD patients and the association with a more aggressive disease phenotype have been previously reported and implied in functional GM-CSF deficiency caused by antibody interference with GM-CSF binding to its receptor [39, 40]. The gene discussed is CSF2; the disease is irritable bowel syndrome.